Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for ICARES Medicus, Inc. (6612:TWSE), powered by AI.
ICARES Medicus, Inc. is currently trading at $72.70. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for ICARES Medicus, Inc. on Alpha Lenz.
View ICARES Medicus, Inc.'s valuation metrics on Alpha Lenz.
“ICARES Medicus, Inc.'s ROE is 2.9%. Explore profitability and growth together.”
Ask for details →ICARES Medicus, Inc. is a healthcare company specializing in the research, development, manufacturing, and sale of ophthalmic medical devices and nanomedical materials. The company's primary products include intraocular lenses designed to address various eye conditions such as cataract, myopia, hyperopia, presbyopia, and astigmatism, as well as surgical implant systems and related technical services. In addition to devices for vision correction, ICARES Medicus, Inc. offers advanced nanomedical lubricious coatings and specialized surface treatments for other implantable and interventional medical devices, supporting broader innovation within the medical technology sector. Operating internationally, the company serves markets in Taiwan, China, the United States, Japan, Spain, and England. Founded in 2011 and based in Zhubei City, Taiwan, ICARES Medicus, Inc. contributes to the advancement of healthcare technology by providing essential solutions for ophthalmic surgery and medical device enhancement, positioning itself as a significant player in the global medical instruments and supplies industry.
“ICARES Medicus, Inc.'s ROE is 2.9%. Explore profitability and growth together.”
Ask for details →ICARES Medicus, Inc. (ticker: 6612) is a company listed on TWSE in the Healthcare sector (Medical Instruments & Supplies).
The current price is 72.7 with a P/E ratio of -x and P/B of -x.
ROE is 2.93% and operating margin is 11.36%. Annual revenue is $1.1B.